Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
171,717,172
-
Number of holders
-
111
-
Total 13F shares, excl. options
-
87,273,471
-
Shares change
-
-3,032,686
-
Total reported value, excl. options
-
$3,627,103,378
-
Value change
-
-$126,698,431
-
Number of buys
-
60
-
Number of sells
-
-31
-
Price
-
$41.56
Significant Holders of Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY) as of Q4 2020
123 filings reported holding RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q4 2020.
Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY) has 111 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 87,273,471 shares
of 171,717,172 outstanding shares and own 50.82% of the company stock.
Largest 10 shareholders include SB INVESTMENT ADVISERS (UK) LTD (27,904,963 shares), TRV GP III, LLC (10,551,115 shares), FMR LLC (4,762,238 shares), Casdin Capital, LLC (3,808,894 shares), EcoR1 Capital, LLC (3,200,649 shares), BlackRock Inc. (3,156,974 shares), BVF INC/IL (3,073,147 shares), TRV GP IV, LLC (2,811,197 shares), PERCEPTIVE ADVISORS LLC (2,329,407 shares), and Foresite Capital Management IV, LLC (2,139,380 shares).
This table shows the top 111 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.